BPC-157
Peptide derived from a protein found in human gastric juice. Extensively studied in animal models for tissue regeneration, wound healing, and gastrointestinal protection. Extremely popular in the biohacking community, but no published human clinical studies exist.
Last updated:: 06/04/2026
Research Status
ANVISA (Brazil)
Not regulated
FDA (USA)
Compounding only
EMA (Europe)
Not regulated
Mechanism of Action
BPC-157 is a pentadecapeptide (15 amino acids) that appears to act through multiple mechanisms: it stimulates angiogenesis (new blood vessel formation), modulates the nitric oxide system, interacts with the dopaminergic system, and promotes the expression of growth factors. In animal models, it has been shown to accelerate healing of tendons, muscles, bones, skin, and gastrointestinal mucosa.
Study Protocols
Dosages and regimens used in published clinical studies. This does not constitute a medical prescription.
Cicatrização de tendões e lesões musculoesqueléticas
Subcutânea (SC) ou Intramuscular (IM)Aplicar próximo ao local da lesão
Majoritariamente estudos em animais. Doses humanas extrapoladas com base em equivalência alométrica. Sem ensaios clínicos fase III em humanos.
Proteção gastrointestinal
OralEm jejum, 30 min antes das refeições
BPC-157 demonstrou estabilidade gástrica superior a outros peptídeos. Dados predominantemente pré-clínicos.
Benefits
Tendon and ligament healing
Under researchMultiple rat studies demonstrated accelerated Achilles tendon and ligament healing. No published human studies.
View studyGastrointestinal protection
Under researchIn animal models, it protects against gastric ulcers, colitis, and NSAID-induced intestinal damage. Derived from a natural gastric protein.
View studyMuscle healing
Under researchRat studies showed accelerated recovery from muscle injuries. Promising results but limited to animal models.
Risks and Side Effects
Unknown safety in humans
High(Unknown)No published human clinical trials. The safety profile is based solely on animal studies, which are not directly transferable to humans.
Product contamination
High(Variable)Products sold as 'research chemicals' frequently do not undergo rigorous quality control. Risk of contamination, incorrect dosing, or adulteration.
Internet vs. Science
What people say online compared to the actual scientific evidence.
Heals any injury
InconclusiveWhat they claim
Online communities promote BPC-157 as a universal cure for muscle, tendon, joint, and even brain injuries.
Actual evidence
Animal results are promising for wound healing, but ZERO human clinical studies have been published. Extrapolating results from rats to humans is scientifically inadequate.
It's completely safe because it's natural
FalseWhat they claim
Because it's derived from a human stomach protein, influencers consider it safe.
Actual evidence
Being derived from a human protein does not guarantee safety. Many natural peptides can have unexpected effects at pharmacological doses. Without human safety studies, it is impossible to claim it is safe.
| Claim | O que dizem | Evidência real | Verdict |
|---|---|---|---|
| Heals any injury | Online communities promote BPC-157 as a universal cure for muscle, tendon, joint, and even brain injuries. | Animal results are promising for wound healing, but ZERO human clinical studies have been published. Extrapolating results from rats to humans is scientifically inadequate. | Inconclusive |
| It's completely safe because it's natural | Because it's derived from a human stomach protein, influencers consider it safe. | Being derived from a human protein does not guarantee safety. Many natural peptides can have unexpected effects at pharmacological doses. Without human safety studies, it is impossible to claim it is safe. | False |
Studies and References (1)
Sikiric P, Seiwerth S, Rucman R, et al. — Journal of Physiology and Pharmacology (2016)
Revisão abrangente dos efeitos do BPC-157 em modelos animais de lesões gastrointestinais, musculoesqueléticas e neurológicas. Todos os estudos em animais.
PubMedFrequently Asked Questions
Is BPC-157 legal in Brazil?
BPC-157 is not a medication approved by ANVISA. There is no specific regulation for its therapeutic use in Brazil. Products sold as 'for research' operate in a regulatory gray area.
Why are there no human studies?
Human clinical trials are expensive and complex. Since BPC-157 is a natural peptide that cannot be easily patented, there is little economic incentive for pharmaceutical companies to invest in phase 1-3 clinical studies.
Important notice
This content is strictly informational and educational, based on published scientific research. It does not constitute medical advice, prescription, or encouragement to use any substance. Always consult a qualified physician before starting any treatment.
How to Obtain
This compound can be prepared by licensed compounding pharmacies with a valid prescription. Consult a physician first.